JPRN-jRCT1080221989未知Unknown
Phase I/II study of Amrubicin with Cisplatin in patients with advanced Non-small cell lung cancer
适应症
试验速览
- 阶段
- Unknown
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Patients with advanced non-small cell lung cancer who satisfy the following inclusion criteria
- •-No prior chemotherapy
- •-Performance status of 0-1
排除标准
- •-Prior radiotherapy for primary lesion
- •-Pneumonitis and/or pulmonary fibrosis
- •-Active concomitant malignancy
研究者
相似试验
招募中
1 期
Phase I study of Amrubicin plus CISplatin and concurrent accelerated hyperfractionated thoracic radioTherapy for limited-disease small cell lung cancerJPRN-jRCT1071200033Taniguchi Hirokazu9
已完成
1 期
Phase 1-2 Study of Amrubicin plus Nedaplatin for Advanced Non-Small-Cell Lung Canceron-Small-Cell Lung CancerJPRN-UMIN000003282agasaki University Hospital35
已完成
2 期
Phase II trial of amrubicin and cisplatin chemotherapy for invasive thymomathymomaJPRN-UMIN000003933West Japan Oncology Group40
已完成
2 期
A phase II study of carboplatin and amurubicin with a biweekly schedule in patients with advanced squamous cell lung canceron-Small Cell Lung Cancer,Squamous cell lung cancerJPRN-UMIN000007102ational Hospital Organization Kyushu Medical Center Department of Respiratory Medicine25
已完成
不适用
Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinomaThymoma/Thymic carcinomaJPRN-UMIN000002619Tohoku University Hospital40